Literature DB >> 6748156

A correlation of toxicity of albendazole and oxfendazole with their free metabolites and bound residues.

P Delatour, F Garnier, E Benoit, C Longin.   

Abstract

The possible correlations between embryotoxicity, plasma kinetics of toxic metabolites and covalent binding of metabolites to foetal tissues were studied using two drugs, albendazole and oxfendazole. In the rat, the metabolic inhibitor, SKF-525A, induced changes in embryotoxicity which were well correlated with plasma levels of identified embryotoxic metabolites, but not with the levels of foetal tissue bound drug metabolites.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6748156     DOI: 10.1111/j.1365-2885.1984.tb00890.x

Source DB:  PubMed          Journal:  J Vet Pharmacol Ther        ISSN: 0140-7783            Impact factor:   1.786


  6 in total

1.  Efficacy of albendazole and mebendazole against Hymenolepis microstoma and Hymenolepis diminuta.

Authors:  R O McCracken; K B Lipkowitz; N O Dronen
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

2.  Study of the in vitro bioactivation of albendazole in human liver microsomes and hepatoma cell lines.

Authors:  S Rolin; H Souhaili-el Amri; A M Batt; M Levy; D Bagrel; G Siest
Journal:  Cell Biol Toxicol       Date:  1989-01       Impact factor: 6.691

3.  Sulfoxidation of albendazole by a cytochrome P450-independent monooxygenase from rat liver microsomes.

Authors:  X Fargetton; P Galtier; P Delatour
Journal:  Vet Res Commun       Date:  1986-07       Impact factor: 2.459

Review 4.  Pharmacokinetic optimisation of the treatment of neurocysticercosis.

Authors:  J Sotelo; H Jung
Journal:  Clin Pharmacokinet       Date:  1998-06       Impact factor: 6.447

5.  Triclabendazole sulfoxide causes stage-dependent embryolethality in zebrafish and mouse in vitro.

Authors:  Nuria Boix; Elisabet Teixido; Marta Vila-Cejudo; Pedro Ortiz; Elena Ibáñez; Juan M Llobet; Marta Barenys
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

6.  Assessment of serum pharmacokinetics and urinary excretion of albendazole and its metabolites in human volunteers.

Authors:  Laura Ceballos; Alejandro Krolewiecki; Marisa Juárez; Laura Moreno; Fabian Schaer; Luis I Alvarez; Rubén Cimino; Judd Walson; Carlos E Lanusse
Journal:  PLoS Negl Trop Dis       Date:  2018-01-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.